| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/01/2000 | EP0982315A2 Preparation of sterol and stanol esters |
| 03/01/2000 | EP0982307A2 9 -Amino- and 9-nitro-camptothecin derivatives, process for their preparation and use as antitumor agents |
| 03/01/2000 | EP0982305A1 Indane-1-ol derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/01/2000 | EP0982304A1 Piperidine derivatives having effects on serotonin related systems |
| 03/01/2000 | EP0982300A2 Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications |
| 03/01/2000 | EP0982037A1 Preventives and/or remedies for sepsis |
| 03/01/2000 | EP0982032A2 Use of a ring system compound comprising a sulphamic acid ester group for the manufacture of medicaments for the control of oestrogen production |
| 03/01/2000 | EP0982030A2 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands |
| 03/01/2000 | EP0981967A1 Feed composition for broilers and method for breeding broilers |
| 03/01/2000 | EP0981649A1 Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same |
| 03/01/2000 | EP0981618A1 Apo-2 RECEPTOR |
| 03/01/2000 | EP0981612A2 Secreted proteins and polynucleotides encoding them |
| 03/01/2000 | EP0981610A2 Compositions for treatment of disorders involving programmed cell death |
| 03/01/2000 | EP0981538A1 Pharmaceutically acceptable salts of 5alpha-pregnan-3beta, 16alp ha-diol-20-one 3-sulfate useful as progestins and cns disorders |
| 03/01/2000 | EP0981534A2 Dinucleotides and their uses |
| 03/01/2000 | EP0981526A1 Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
| 03/01/2000 | EP0981523A1 CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1$g(a) (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF |
| 03/01/2000 | EP0981521A2 Novel macrocyclic compounds as metalloprotease inhibitors |
| 03/01/2000 | EP0981520A1 Efficient enantioselective addition reaction using an organozinc reagent |
| 03/01/2000 | EP0981519A1 Methods of modulating serine/threonine protein kinase function with quinazoline-based compounds |
| 03/01/2000 | EP0981517A1 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents |
| 03/01/2000 | EP0981516A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d?3 receptors |
| 03/01/2000 | EP0981515A1 Piperidine derivatives as neurotransmitter re-uptake inhibitors |
| 03/01/2000 | EP0981514A1 3-epi vitamin d2 compounds and uses thereof |
| 03/01/2000 | EP0981376A1 Targeted therapeutic delivery of vitamin d compounds |
| 03/01/2000 | EP0981369A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors |
| 03/01/2000 | EP0981359A1 Compositions for enhancing immunosuppressants' pharmaceutical activities |
| 03/01/2000 | EP0981346A1 Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes |
| 03/01/2000 | EP0981345A1 Methods and compositions for the protection of mitochondria |
| 03/01/2000 | EP0981343A2 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 03/01/2000 | EP0981340A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 03/01/2000 | EP0981339A1 Use of a pharmaceutical composition for treating and/or preventing ischemia |
| 03/01/2000 | EP0981327A2 Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors |
| 03/01/2000 | EP0981309A2 Differential treatment of prosthetic devices |
| 03/01/2000 | EP0861070B1 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 03/01/2000 | EP0821592A4 Compositions and methods for regulating hair growth |
| 03/01/2000 | EP0513387B1 Thiazole derivatives as active oxygen inhibitors |
| 03/01/2000 | CN1246154A OB fusion protein compositions and methods |
| 03/01/2000 | CN1246117A 1,2-dihydroindene or indoline derivatives |
| 03/01/2000 | CN1246116A Sulphonamide derivatives, process for their preparation and their use as medicaments |
| 03/01/2000 | CN1246113A Process for crystallization of reverse transcriptase inhibitor using anti-solvent |
| 03/01/2000 | CN1246109A 5-aroylnaphthalene derivatives |
| 03/01/2000 | CN1246056A Mycobacterium vaccae for down-regulation of THz activity of immune system |
| 03/01/2000 | CN1245810A Preparation of sterol and dihydro-sterol ester |
| 03/01/2000 | CN1245803A Method for preparing substituted pyridines |
| 03/01/2000 | CN1245798A New hydroxamic acid compounds, their preparation method and medicine composition containing them |
| 03/01/2000 | CN1245706A Face-nourishing oral liquor and its preparation method |
| 03/01/2000 | CN1245690A Scorpion health-care wine |
| 03/01/2000 | CN1049891C Dicyclomine compound and preparing method, and drug composition containing said compound |
| 03/01/2000 | CN1049824C Anti-senility medicine and its preparing method |
| 03/01/2000 | CN1049818C Pharmaceutical use of benzo-thiophenes compound |
| 03/01/2000 | CA2246791A1 Treatment of endothelium with somatostatin analogues |
| 02/29/2000 | US6031072 Compounds and methods for modulating cell adhesion |
| 02/29/2000 | US6031000 Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use |
| 02/29/2000 | US6030989 Hemoregulatory compounds |
| 02/29/2000 | US6030985 Stroke, schizophrenia, antianxiolytic and antihypoxia agents, analgesics; neurodegenerative disorders, e.g., nerve degeneration and/or necrosis; hyperglycemic, antiepileptic and antiinflammatory agents; drug abuse; |
| 02/29/2000 | US6030979 Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Quinolizinium derivatives and the salts thereof |
| 02/29/2000 | US6030961 Oxyalkylene phosphate compounds and uses thereof |
| 02/29/2000 | US6030953 For preventing and treating anal leakage of oil in a patient |
| 02/29/2000 | US6030946 Reversible cysteine protease inhibitors |
| 02/29/2000 | US6030945 Apo-2 ligand |
| 02/29/2000 | US6030837 Antisense inhibition of PEPCK-mitochondrial expression |
| 02/29/2000 | US6030831 Tie ligand homologues |
| 02/29/2000 | US6030825 Cyclophilin-type peptidyl-prolyl cis/trans isomerase |
| 02/29/2000 | US6030822 Amino acid sequence; for treating skeletal muscle diseases, alzheimer's disease, or peripheral neuropathies in a mammal with an agonist or antagonist of kinase activity; antidiabetic agents |
| 02/29/2000 | US6030622 Herbal extract composition and method with immune-boosting capability |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030615 Combination method for treating diseases caused by cytokine-mediated toxicity |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | US6030611 Administering cuzn superoxide dismutase to organ recipient following transplantation |
| 02/29/2000 | CA2281050A1 Nitric oxide releasing oxindole prodrugs for analgesic, anti-inflammatory and disease-modifying use |
| 02/29/2000 | CA2280049A1 Diarylsulfonylurea binding proteins |
| 02/29/2000 | CA2169179C 5-arylindole derivatives |
| 02/29/2000 | CA2050072C Liposome for entrapping gene, liposomal preparation and process for the manufacture of the preparation |
| 02/28/2000 | CA2281055A1 Antithrombin iii-beta-comprising pharmaceutical preparation |
| 02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
| 02/24/2000 | WO2000009709A2 Proteases and associated proteins |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009668A1 Engraftable human neural stem cells |
| 02/24/2000 | WO2000009560A2 Generation of modified molecules with increased serum half-lives |
| 02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |
| 02/24/2000 | WO2000009506A1 1h-imidazopyridine derivatives |
| 02/24/2000 | WO2000009504A1 Substituted 1,8-naphthyridin-4(1h)-ones as phosphodiesterase 4 inhibitors |
| 02/24/2000 | WO2000009498A1 Prodrugs of proton pump inhibitors |
| 02/24/2000 | WO2000009496A1 Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 02/24/2000 | WO2000009495A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 02/24/2000 | WO2000009492A1 Tace inhibitors |
| 02/24/2000 | WO2000009489A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009479A2 Heterocyclic thioesters or ketones for vision and memory disorders |
| 02/24/2000 | WO2000009162A1 Preventives/remedies for glaucoma |
| 02/24/2000 | WO2000009153A1 Compositions and methods for treating lysosomal storage disease |
| 02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
| 02/24/2000 | WO2000009126A1 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 02/24/2000 | WO2000009124A1 Pyrrolidine derivatives for vision and memory disorders |
| 02/24/2000 | WO2000009123A1 Pharmaceutical compositions containing lipase inhibitors and chitosan |
| 02/24/2000 | WO2000009122A1 Pharmaceutical compositions containing lipase inhibitors |